The nation of Zimbabwe has declined a substantial American healthcare agreement worth 367 million US dollars (272 million pounds) over five years because of Washington's demand for confidential information.
This rejection became public following a official document dated December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the arrangement was "skewed".
An official representative has since stated that the US was requesting health data for scientific study and commercial gain while was unwilling to guarantee the benefits from any future vaccines.
"We are forced to start the difficult and regrettable process of winding down our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had furnished over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged more dialogue to reach a agreement acceptable to both sides so the country's vital HIV treatment initiative can proceed.
Broader Implications
This development follows a comparable situation in neighbouring Kenya, where a high court suspended a related health funding agreement following concerns were raised about the security of Kenyans' medical information.
After resuming office last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
The agency had administered aid for the US government, but Trump argued its spending was "inefficient" and his government was seeking government-to-government agreements to boost openness and accountability.
Based on statements, 16 nations in Africa have so far signed similar agreements, representing more than $18.3bn in new funding.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation could have provided extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently on HIV treatment via American-funded initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"Our nation was requested to surrender its genetic material and health information over an extended period, with no corresponding assurance of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"Effectively, our nation would supply the basic resources for medical research with no certainty that the final treatments would be accessible to our citizens if a new disease outbreak emerge."
Sovereignty and Global Health
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were disrupting frameworks already set up via the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential global health emergencies.
"This system is designed to guarantee that when a nation provides its samples, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the funds to develop them."
These objections regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We are open to ongoing dialogue with our US partners on how subsequent collaboration might be arranged in a way that honours the independence and dignity of each country."
Health Experts Reaction
Medical experts said it recognised the official position, but recommended that talks need to persist given that much of the country's HIV programmes were funded by international support.
"If technical issues exist, such as those relating to information security or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," the group said.
This impasse highlights the continuing challenges between accepting much-needed international aid and safeguarding local interests in an increasingly interconnected world.